GLP-1 adoption weighing on packaged snack sales
Rising GLP-1 drug adoption is creating a structural volume drag on packaged sweet snack manufacturers.
Keep reading this one
You've read the thesis and who argued it. A free account opens the argument, what validates it, the risks the show raised, and the moment in the episode where it was said — 3 ideas in full a day, no card.